DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
for Medulloblastoma
23 locations incl. Little Rock
Sponsor: Giselle Sholler
Sex: All·Age: Up to 21
Code: NCT04696029·Phase 2·Recruiting·Listed Jan 2021
Clinical research site in Chicago, Illinois
Part of Advocate Aurora Research Institute
As of July 2026, 1 paid clinical trial is recruiting at Advocate Aurora Research Institute in Chicago, Illinois. Active studies at this site focus on Medulloblastoma alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Paid clinical trials in Chicago, IL · Illinois clinical trials